全文获取类型
收费全文 | 2258篇 |
免费 | 191篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 29篇 |
妇产科学 | 15篇 |
基础医学 | 212篇 |
口腔科学 | 21篇 |
临床医学 | 141篇 |
内科学 | 272篇 |
皮肤病学 | 33篇 |
神经病学 | 89篇 |
特种医学 | 53篇 |
外科学 | 144篇 |
综合类 | 253篇 |
预防医学 | 157篇 |
眼科学 | 11篇 |
药学 | 843篇 |
中国医学 | 155篇 |
肿瘤学 | 37篇 |
出版年
2024年 | 6篇 |
2023年 | 30篇 |
2022年 | 60篇 |
2021年 | 70篇 |
2020年 | 58篇 |
2019年 | 57篇 |
2018年 | 58篇 |
2017年 | 43篇 |
2016年 | 81篇 |
2015年 | 84篇 |
2014年 | 140篇 |
2013年 | 240篇 |
2012年 | 136篇 |
2011年 | 157篇 |
2010年 | 144篇 |
2009年 | 117篇 |
2008年 | 89篇 |
2007年 | 114篇 |
2006年 | 99篇 |
2005年 | 90篇 |
2004年 | 83篇 |
2003年 | 64篇 |
2002年 | 57篇 |
2001年 | 54篇 |
2000年 | 47篇 |
1999年 | 28篇 |
1998年 | 23篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 15篇 |
1994年 | 19篇 |
1993年 | 8篇 |
1992年 | 9篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 6篇 |
1987年 | 7篇 |
1985年 | 10篇 |
1983年 | 13篇 |
1982年 | 9篇 |
1978年 | 7篇 |
1975年 | 13篇 |
1974年 | 11篇 |
1973年 | 15篇 |
1972年 | 8篇 |
1971年 | 9篇 |
1970年 | 5篇 |
1969年 | 11篇 |
1968年 | 6篇 |
排序方式: 共有2477条查询结果,搜索用时 46 毫秒
1.
2.
3.
Hepatitis C is a major public health problem worldwide. This disease is caused by the hepatitis C virus, which is characterised by its genetic diversity. The infection is usually asymptomatic. However, between 60% and 80% of HCV-infected individuals will progress to chronic hepatitis, 20% to liver cirrhosis in the medium-to long-term and, each year, between 1% and 4% of these patients with cirrhosis will develop hepatocellular carcinoma (HCC). A Spanish consensus document has recently been drafted to diagnose hepatitis C in a single step, consisting of active investigation (antibodies and viremia) in a single sample, which according to the experts, would reduce the time to access treatment and avoid tracking losses. To definitively change the hepatitis C treatment paradigm, direct-acting antiviral drugs (DAAs) have been approved, whose development has been based on achieving cure rates close to 100% regardless of the genotype of the virus, ie, pangenotypes, with good tolerance and bioavailability. These drugs have constituted a real therapeutic revolution. Supplement information: This article is part of a supplement entitled «SEIMC External Quality Control Programme. Year 2016», which is sponsored by Roche, Vircell Microbiologists, Abbott Molecular and Francisco Soria Melguizo, S.A.© 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosasy Microbiología Clínica. All rights reserved. 相似文献
4.
目的:探索中药水蛭、海螵蛸、阿胶、骨碎补在骨折愈合过程中的干预作用,了解它们各自的调节靶点,探索建构其基因组学的途径。方法:通过在大鼠胫骨打孔的方法建立单因素干扰模型,并将300只大鼠随机分为正常组、模型组和给药组(分别用4种中药给药),每组50只,分别在实验的第4、7、14、21、28天不同时间点采用原位杂交方法对各类mRNA的变化进行动态观察,分析骨愈合过程中Ⅰ、Ⅱ、Ⅲ型前胶原mRNA、转化生长因子TGF-β1mRNA、骨形态发生蛋白BMP-2mRNA以及血管内皮生长因子VEGF-mRNA的表达情况。结果:不同中药对不同基因的作用不同,作用的时间点不同,作用强度也存在差异。其中海螵蛸在骨折早期对Ⅰ、Ⅲ型前胶原mRNA、VEGF-mRNA、BMP-2mRNA的表达升高,后期Ⅱ、Ⅲ型前胶原mRNA表达水平下降,VEGF-mRNA、TGF-β1mRNA表达量维持于较高水平;骨碎补组较模型组在BMP-2mRNA、TGF-β1mRNA、Ⅰ型前胶原mRNA的表达上差异有显著性统计意义;阿胶对骨愈合早、中期Ⅰ、Ⅱ、Ⅲ型前胶原mRNA和TGF-β1mRNA的表达与模型组比较差异存在显著性统计意义;水蛭对VEGF-mRNA的表达具有一定的促进作用。结论:海螵蛸、水蛭对血管形成有促进作用,阿胶、骨碎补和海螵蛸对骨折软骨形成早期具有促进骨诱导的作用,并对成骨细胞的增殖及合成活性有较大影响。 相似文献
5.
目的 :探讨应用射频与中药联合治疗肥厚性咽炎的疗效。方法 :随机将 16 8例肥厚性咽炎患者分为射频与中药联合治疗组和对照组 ,进行临床观察。结果 :治疗组显效率 76 .3% ,总有效率 10 0 % ,对照组显效率 14 % ,总有效率 82 % ,两组差异有高度显著性 (P<0 .0 1)。 结论 :射频配合中药联合治疗肥厚性咽炎效果显著。 相似文献
6.
7.
M. Addy 《Journal of clinical periodontology》1986,13(10):957-964
Based on the association of bacterial plaque with the initiation of chronic gingivitis and progression of chronic periodontitis, chemical antiplaque agents have been employed both in prevention of periodontal disease and its treatment. In supragingival plaque control regimens, chlorhexidine has not been superceded as a chemical anti-plaque agent, although other compounds have been shown to be useful. The local side-effects of chlorhexidine and other cationic antiseptics, however, limit their long-term use for prevention. Extrinsic tooth staining in particular remains the greatest problem. Short-term anti-plaque uses for chlorhexidine include as an adjunct to mechanical cleaning in the initial oral hygiene phase of treatment, in situations where mechanical oral hygiene is difficult, including postsurgery, intermaxillary fixation, fixed orthodontic therapy, physically and mentally handicapped individuals, systemic diseases with oral manifestations such as leukaemia. More recent interest in chlorhexidine has resulted from the delivery of compounds subgingivally in the treatment of chronic periodontitis. Such methods have extended the use of chlorhexidine into areas inaccessible to the action of antimicrobial drugs delivered locally by conventional means, such as tooth brushing or mouth rinsing. Available evidence suggests that chlorhexidine may not be as effective as some antimicrobial drugs whose activity is more specific for those organisms considered particularly pathogenic to the periodontal tissues. 相似文献
8.
N. F. Wieringa A. H. R. de Meijer M. D. B. Schutjens R. Vos 《Social science & medicine (1982)》1992,35(12):1497-1504
The market of non-registered pharmaceutical products is growing fast in number and overall costs, not only in the Netherlands, but also in other European countries. These products often give the impression that the consumer may expect 'an effect as from a drug'. Legally, there is a clear distinction between 'drugs' and 'commodities' in the Netherlands; the question is whether legislation and practice concur. In an investigation we analysed texts of advertisements for non-registered pharmaceutical products published in a popular magazine. A method was developed, based on the legal definition of a drug and jurisprudence, to determine in a qualitative and quantitative way the application of medicinal claims. It transpired that in 65% of the analysed advertisements explicit or implicit claims were made. These products should therefore be subject to drugs legislation. Thus, in the Netherlands there is a gap between legislation and practice in advertising non-registered pharmaceutical products. 相似文献
9.
Jonathan Appel Dohee Kim-Appel 《International journal of mental health and addiction》2007,5(3):248-253
Since the 1990s, there has been a rise in the availability and recreational use of a herbal plant called Salvia divinorum. Numerous internet websites have advertised it for sale as a legal herbal alternative to illegal hallucinogens. Initial data
surveying use has indicated many young adults are obtaining and using this herb for its psychoactive properties. Reported
methods of ingestion for the plant include chewing, and smoking leaves or fortified extracts. Subjective effects of the plant
include, affect changes, psychedelic-like changes in perception, and even loss of consciousness. Although the pharmacological
properties and possible antidepressant effects have been studied in recent years, little information is known about potential
negative impact resulting from recreational use, and scant information about Salvia divinorum currently exists in the psychological
and substance abuse literature. While Salvia divinorum appears to be a substance with some therapeutic potential, it also
poses some significant dangers as a substance of varying legal status with a potential for abuse. 相似文献
10.
杨晓玲 《药物流行病学杂志》2003,12(2):68-69
目的:了解伊曲康唑的不良反应及安全性。资料与方法:手工检索《中华皮肤科杂志》等3种中文专业期刊,从对照试验的文献中提取治疗例数和各种不良反应例数,计算发生率。结果:共有14725例涉及有关安全性的报道。伊曲康唑不良反应总的发生率约为1.57%。结论:伊曲康唑较为安全。 相似文献